Published in Nucl Med Biol on January 01, 2005
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev (2010) 2.70
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Deliv Rev (2008) 1.55
Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging. Q J Nucl Med Mol Imaging (2007) 1.17
Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms. Dalton Trans (2011) 1.10
Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator. Bioconjug Chem (2012) 1.03
Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling. Bioconjug Chem (2008) 1.03
A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies. Bioconjug Chem (2007) 1.02
Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging. Bioorg Med Chem (2011) 0.98
64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging. Bioconjug Chem (2011) 0.87
A novel side-bridged hybrid phosphonate/acetate pendant cyclam: synthesis, characterization, and 64Cu small animal PET imaging. Bioorg Med Chem (2008) 0.87
64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics. Bioconjug Chem (2008) 0.83
64Cu-labeled lissamine rhodamine B: a promising PET radiotracer targeting tumor mitochondria. Mol Pharm (2011) 0.82
Applications of LC-MS in PET radioligand development and metabolic elucidation. Curr Drug Metab (2010) 0.80
Evaluation of 64Cu-labeled acridinium cation: a PET radiotracer targeting tumor mitochondria. Bioconjug Chem (2011) 0.79
Optical imaging of tumors with copper-labeled rhodamine derivatives by targeting mitochondria. Theranostics (2012) 0.79
Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development. Chem Sci (2016) 0.78
Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers. Front Oncol (2013) 0.75
Real-time Detection of Trace Copper in Brain and Kidney of Fish for Medical Diagnosis. Toxicol Res (2014) 0.75
Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem (2004) 3.57
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev (2010) 2.70
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. J Med Chem (2002) 1.92
Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res (2004) 1.89
Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci U S A (2009) 1.72
Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). Acc Chem Res (2009) 1.49
Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64. Nat Protoc (2006) 1.42
Synthesis and characterization of a macrocyclic near-infrared optical scaffold. J Am Chem Soc (2003) 1.33
Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. Cancer Biother Radiopharm (2008) 1.30
Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J Med Chem (2007) 1.30
In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. J Nucl Med (2003) 1.22
The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals. J Nucl Med (2013) 1.22
(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Nucl Med Biol (2009) 1.14
Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. ACS Nano (2011) 1.13
Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. J Nucl Med (2007) 1.10
Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms. Dalton Trans (2011) 1.10
Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors. J Nucl Med (2008) 1.10
Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjug Chem (2007) 1.09
Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines. J Nucl Med (2008) 1.07
DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjug Chem (2002) 1.07
Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator. Bioconjug Chem (2012) 1.03
A new phosphonate pendant-armed cross-bridged tetraamine chelator accelerates copper(ii) binding for radiopharmaceutical applications. Dalton Trans (2009) 1.03
Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer. Cancer Res (2003) 1.01
Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Curr Pharm Des (2008) 1.00
In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer. J Nucl Med (2011) 1.00
Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nucl Med Biol (2005) 1.00
The long and short of it: the influence of N-carboxyethyl versusN-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles. Dalton Trans (2007) 1.00
Inside or outside a ligand cleft? Synthetic, structural, and kinetic inertness studies of zinc, cadmium, and mercury complexes of cross-bridged cyclam and cyclen. Dalton Trans (2004) 0.97
In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands. J Biol Inorg Chem (2002) 0.96
Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. Mol Imaging (2009) 0.95
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer. J Med Chem (2014) 0.94
In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models. Nucl Med Biol (2006) 0.94
Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects. Bioconjug Chem (2010) 0.93
Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents. Inorg Chem (2009) 0.93
New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides. Chem Commun (Camb) (2014) 0.91
Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases. J Nucl Med (2009) 0.91
Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy. Cancer Biol Ther (2011) 0.90
Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma. PLoS One (2013) 0.90
Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist. Mol Imaging Biol (2012) 0.90
Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy. Nucl Med Biol (2011) 0.89
Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line. J Nucl Med (2007) 0.89
Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women. Cancer (2007) 0.89
Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells. Mol Imaging (2007) 0.88
Production and applications of copper-64 radiopharmaceuticals. Methods Enzymol (2004) 0.88
Psychosocial costs of racism to Whites: Understanding patterns among university students. J Couns Psychol (2009) 0.87
Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche. J Nucl Med (2012) 0.87
The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice. Magn Reson Med (2010) 0.87
Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice. Mol Pharm (2014) 0.86
Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors. Nucl Med Biol (2012) 0.86
Radioactivity-synchronized fluorescence enhancement using a radionuclide fluorescence-quenched dye. J Am Chem Soc (2009) 0.86
Online racial discrimination and the protective function of ethnic identity and self-esteem for African American adolescents. Dev Psychol (2012) 0.86
The role of p53 in the trafficking of copper-64 to tumor cell nuclei. Cancer Biol Ther (2007) 0.85
Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. Mol Imaging Biol (2012) 0.85
64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. J Med Chem (2014) 0.84
The effects of print exposure on sentence processing and memory in older adults: Evidence for efficiency and reserve. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2011) 0.84
Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals. J Labelled Comp Radiopharm (2013) 0.84
Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy. J Biol Inorg Chem (2014) 0.83
In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas. Cancer Biother Radiopharm (2010) 0.83
The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer. J Nucl Med (2013) 0.82
Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems. J Drug Deliv (2012) 0.82
In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands. Nucl Med Biol (2004) 0.81
Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy. Methods Mol Biol (2007) 0.81
Rapid and sensitive LC-MS approach to quantify non-radioactive transition metal impurities in metal radionuclides. Chem Commun (Camb) (2013) 0.81
Developmental changes in sexual prejudice from early to late adolescence: the effects of gender, race, and ideology on different patterns of change. Dev Psychol (2012) 0.81
A potential Dubin-Johnson syndrome imaging agent: synthesis, biodistribution, and microPET imaging. Mol Imaging (2005) 0.80
The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow. Pancreas (2015) 0.79
Effects of thrombolysis for acute stroke in patients with pre-existing disability. CMAJ (2003) 0.79
Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes. Dalton Trans (2008) 0.79
Comparative analysis of folate derived PET imaging agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model. Mol Pharm (2013) 0.78
Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6. Mol Imaging Biol (2014) 0.77
Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model. Mol Pharm (2015) 0.77
Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Mol Imaging (2014) 0.76
Isomeric trimethylene and ethylene pendant-armed cross-bridged tetraazamacrocycles and in vitro/in vivo comparisions of their copper(II) complexes. Inorg Chem (2011) 0.76
A new vision for the MICoE. J Nucl Med (2010) 0.76
Cu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides. Dalton Trans (2015) 0.76
Council-based approaches to intimate partner violence: evidence for distal change in the system response. Am J Community Psychol (2013) 0.76
Investigation of copper-azamacrocyclic complexes by high-performance liquid chromatography. Biomed Chromatogr (2006) 0.76
Young ischaemic stroke in South Auckland: a hospital-based study. N Z Med J (2012) 0.76